Mutation load and an effector T-cell gene signature may distinguish immunologically distinct and clinically relevant lymphoma subsets.

Bolen, Christopher R; McCord, Ronald; Huet, Sarah; Frampton, Garrett M; Bourgon, Richard; Jardin, Fabrice; Dartigues, Peggy; Punnoose, Elizabeth A; Szafer-Glusman, Edith; Xerri, Luc; Sujobert, Pierre; Salles, Gilles; Venstrom, Jeffrey M.

Afiliação

Bolen CR; Bioinformatics and.
McCord R; Oncology Biomarker Development, Genentech, South San Francisco, CA.
Huet S; Laboratory of Hematology, Lyon-Sud Hospital Center, Pierre-Benite, France.
Frampton GM; Cancer Research Center of Lyon, INSERM U1052, Unité Mixte de Recherche Centre National de la Recherche Scientifique 5286, Lyon, France.
Bourgon R; Foundation Medicine, Inc, Cambridge, MA.
Jardin F; Bioinformatics and.
Dartigues P; Henri Becquerel Center, Rouen, France.
Punnoose EA; Gustave Roussy Institute, Villejuif, France; and.
Szafer-Glusman E; Oncology Biomarker Development, Genentech, South San Francisco, CA.
Xerri L; Oncology Biomarker Development, Genentech, South San Francisco, CA.
Sujobert P; Department of Bio-Pathology, Hematology, and Tumor Immunology, and.
Salles G; Paoli-Calmettes Institute, Aix-Marseille University, Marseille, France.
Venstrom JM; Laboratory of Hematology, Lyon-Sud Hospital Center, Pierre-Benite, France.

Blood Adv ; 1(22): 1884-1890, 2017 Oct 10.

Article em En | MEDLINE | ID: mdl-29296835

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article